v3.26.1
Acquisitions, Divestitures and Strategic Investments - Level 3 Contingent Consideration (Details) - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Business Combination [Line Items]    
Contingent consideration liability $ 257 $ 385
Revenue-based Payments and Commercialization Milestones | Discount Rate    
Business Combination [Line Items]    
Contingent consideration liability $ 76  
Revenue-based Payments and Commercialization Milestones | Discount Rate | Minimum    
Business Combination [Line Items]    
Discount Rate, Fair Value Input 6.00%  
Probability of Payment 90.00%  
Revenue-based Payments and Commercialization Milestones | Discount Rate | Maximum    
Business Combination [Line Items]    
Discount Rate, Fair Value Input 15.00%  
Probability of Payment 100.00%  
Revenue-based Payments and Commercialization Milestones | Discount Rate | Weighted Average    
Business Combination [Line Items]    
Discount Rate, Fair Value Input 10.00%  
Probability of Payment 98.00%  
Clinical-based, Regulatory and Other Milestones | Discount Rate    
Business Combination [Line Items]    
Contingent consideration liability $ 181  
Clinical-based, Regulatory and Other Milestones | Discount Rate | Minimum    
Business Combination [Line Items]    
Discount Rate, Fair Value Input 4.00%  
Probability of Payment 74.00%  
Clinical-based, Regulatory and Other Milestones | Discount Rate | Maximum    
Business Combination [Line Items]    
Discount Rate, Fair Value Input 5.00%  
Probability of Payment 86.00%  
Clinical-based, Regulatory and Other Milestones | Discount Rate | Weighted Average    
Business Combination [Line Items]    
Discount Rate, Fair Value Input 5.00%  
Probability of Payment 81.00%